Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
Ageing Research Reviews · 2023-07 · 88 · 101960
DOI: 10.1016/j.arr.2023.101960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2023-07. Verfasst von Samridhi Thakral und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 373 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD), also called senile dementia, is the most common neurological disorder. Around 50 million people, mostly of advanced age, are suffering from dementia worldwide and this is expected to reach 100-130 million between 2040 and 2050. AD is characterized by impaired glutamatergic and cholinergic neurotransmission, which is associated with clinical and pathological symptoms. AD is characterized clinically by loss of cognition and memory impairment and pathologically by senile plaques formed by Amyloid β deposits or neurofibrillary tangles (NFT) consisting of aggregated tau proteins. Amyloid β deposits are responsible for glutamatergic dysfunction that develops NMDA dependent Ca2+ influx into postsynaptic neurons generating slow excitotoxicity process leading to oxidative stress and finally impaired cognition and neuronal loss. Amyloid decreases acetylcholine release, synthesis and neuronal transport. The decreased levels of neurotransmitter acetylcholine, neuronal loss, tau aggregation, amyloid β plaques, increased oxidative stress, neuroinflammation, bio-metal dyshomeostasis, autophagy, cell cycle dysregulation, mitochondrial dysfunction, and endoplasmic reticulum dysfunction are the factors responsible for the pathogenesis of AD. Acetylcholinesterase, NMDA, Glutamate, BACE1, 5HT6, and RAGE (Receptors for Advanced Glycation End products) are receptors targeted in treatment of AD. The FDA approved acetylcholinesterase inhibitors Donepezil, Galantamine and Rivastigmine and N-methyl-D-aspartate antagonist Memantine provide symptomatic relief. Different therapies such as amyloid β therapies, tau-based therapies, neurotransmitter-based therapies, autophagy-based therapies, multi-target therapeutic strategies, and gene therapy modify the natural course of the disease. Herbal and food intake is also important as preventive strategy and recently focus has also been placed on herbal drugs for treatment. This review focuses on the molecular aspects, pathogenesis and recent studies that signifies the potential of medicinal plants and their extracts or chemical constituents for the treatment of degenerative symptoms related to AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India.
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India. Electronic address: vikramjeetsinghjudge@gmail.com.
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda 151401, Punjab, India.
- Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra 136119, Haryana, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India.
- Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India. Electronic address: amitaverma…
Zitieren
APA
Thakral, S., Yadav, A., Singh, V., Kumar, M., Kumar, P., Narang, R., Sudhakar, K., Verma, A., Khalilullah, H., Jaremko, M., & Emwas, A. H. (2023). Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs. Ageing Research Reviews, 88, 101960. https://doi.org/10.1016/j.arr.2023.101960
Vancouver
Thakral S, Yadav A, Singh V, Kumar M, Kumar P, Narang R, et al. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs. Ageing Research Reviews. 2023;88:101960. doi:10.1016/j.arr.2023.101960
BibTeX
@article{Thakral2023,
author = {Thakral, Samridhi and Yadav, Alka and Singh, Vikramjeet and Kumar, Manoj and Kumar, Pradeep and Narang, Rakesh and Sudhakar, Kalvatala and Verma, Amita and Khalilullah, Habibullah and Jaremko, Mariusz and Emwas, Abdul-Hamid},
title = {Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs},
journal = {Ageing Research Reviews},
year = {2023},
volume = {88},
pages = {101960},
doi = {10.1016/j.arr.2023.101960}
}
EUVIMED